United Maritime Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-10,080
Closed -$894K – 82
2021
Q1
$894K Buy
+10,080
New +$1,000K 0.74% 26

Other funds holding ARKG

United Maritime Capital's ARKG Position: Q2 2021 in Review

United Maritime Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 10,080 shares — an estimated $894K sold.

United Maritime Capital first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $894K in Q1 2021. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • United Maritime Capital reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • United Maritime Capital sold 10,080 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $894K.
  • United Maritime Capital first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • United Maritime Capital's ARK Genomic Revolution ETF position peaked at $894K in Q1 2021.
  • 514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on United Maritime Capital's 13F filing for Q2 2021, filed 11 Aug 2021.